Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems.
about
Evidence for modulation of pericryptal sheath myofibroblasts in rat descending colon by transforming growth factor beta and angiotensin IIThe Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the LungIncrease of hematopoietic responses by triple or single helical conformer of an antitumor (1-->3)-beta-D-glucan preparation, Sonifilan, in cyclophosphamide-induced leukopenic miceRadiation-induced skin injury in the animal model of scleroderma: implications for post-radiotherapy fibrosisUsing patient data similarities to predict radiation pneumonitis via a self-organizing mapTradeoffs for assuming rigid target motion in Mlc-based real time target tracking radiotherapy: a dosimetric and radiobiological analysis.Investigation of the support vector machine algorithm to predict lung radiation-induced pneumonitisTreating cancer patients. Practical monitoring and management of therapy-related complications.Molecular mechanisms and treatment of radiation-induced lung fibrosisEarly onset recall pneumonitis during targeted therapy with sunitinibStereotactic body radiation therapy (SBRT) for lung cancer patients previously treated with conventional radiotherapy: a review.A neural network model to predict lung radiation-induced pneumonitis.Prospective assessment of dosimetric/physiologic-based models for predicting radiation pneumonitis.Chronic oxidative stress and radiation-induced late normal tissue injury: a review.Radiation Pneumonitis After Conventional Radiotherapy For Breast Cancer: A Prospective Study.Pilot Feasibility Study of Comprehensive Pulmonary Evaluation Following Lung Radiation TherapyIntercellular adhesion molecule 1 knockout abrogates radiation induced pulmonary inflammation.Interstitial Lung Change in Pre-radiation Therapy Computed Tomography Is a Risk Factor for Severe Radiation Pneumonitis.Unexpected Symptomatic Pneumonitis Following Breast Tangent Radiation: A Case ReportAdenosine A2A receptor plays an important role in radiation-induced dermal injuryPerinatal exposure to environmental tobacco smoke (ETS) enhances susceptibility to viral and secondary bacterial infections.Structural and functional alterations in the rat lung following whole thoracic irradiation with moderate doses: injury and recoveryElevation in exhaled nitric oxide predicts for radiation pneumonitis[18F]-FDG uptake dose-response correlates with radiation pneumonitis in lung cancer patients.Management of normal tissue toxicity associated with chemoradiation (primary skin, esophagus, and lung).Proton therapy radiation pneumonitis local dose-response in esophagus cancer patientsThe role of inflammation in the pathogenesis of idiopathic pulmonary fibrosis.Development of a minipig model for lung injury induced by a single high-dose radiation exposure and evaluation with thoracic computed tomography.Interstitial pneumonitis following intrapleural chemotherapy.Combining multiple models to generate consensus: application to radiation-induced pneumonitis predictionPartial frequency of radiation pneumonitis and its association with the energy and treatment technique in patients with breast cancer, Isfahan, Iran.Meta-analysis of incidence of early lung toxicity in 3-dimensional conformal irradiation of breast carcinomas.Pulmonary outcomes in survivors of childhood cancer: a systematic review.Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.Yttrium ibritumomab tiuxetan in the treatment of non-Hodgkin's lymphoma: current status and future prospects.Current concepts in clinical radiation oncology.Treatment for radiation-induced pulmonary late effects: spoiled for choice or looking in the wrong direction?ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.Pneumonitis and pulmonary fibrosis associated with breast cancer treatments.Modeling DNA damage-induced pneumopathy in mice: insight from danger signaling cascades.
P2860
Q24802664-E889A6CA-E3F9-483D-9C25-F8C87A222552Q28070412-2AC3D6F0-1D80-4936-8514-D978C32880D0Q28370557-C9B211BF-DFA0-4A5A-8BA4-712C9CDFAE71Q28756266-8D173FC0-61A4-43E0-AB64-7C1F85603460Q31142281-60044ACE-4EE4-456C-AD5D-4DEB0E492DD8Q33829719-0B75600B-8ADF-4EF0-A326-B4D39ACA16B6Q34060849-319C0973-CE21-48E3-9271-237437E58B65Q34121459-1B24AAD7-849E-4881-B099-EFE4DCA47888Q34142102-A3B56523-44BF-444F-A517-7A1DC5AF11FDQ34530533-D8838A9E-D7EF-41C5-A18E-852123A3A780Q34667302-073EA25E-03FB-47C8-8C3F-E96315C6AD8CQ34699983-8191B147-CB7E-421C-8B12-A23EA275E72FQ35691715-DC97E5DC-DCB4-4631-B9F0-0DC51AB0FB57Q35809682-E0C52D23-78BF-4285-9464-7B8C20CC065AQ36068252-1637043D-438E-4EE5-8E19-D0B421544F6EQ36070386-01659398-42FB-4853-961D-056C62A40D70Q36187098-2B707BA3-4281-47CB-8124-F6F14840CE9EQ36187134-027C5612-AC15-4DF2-AF7E-5014C27689FEQ36319218-FF2D9224-A57D-42EF-BFFE-3828D0D84017Q36385392-8013B4AE-286B-45BD-AAF3-67C8ED9E774BQ36473489-AF2BC8F7-E099-401A-935D-0ACA4E179308Q36731218-C41326A0-CD67-4958-B93A-D8D2AAEA644AQ36766529-29E91518-3002-4F77-B7CF-A4FF4419E3ECQ36766549-F7782937-46AE-40AF-BDC1-0E331E7685C8Q36811458-C60B5CE3-3376-4354-B9BE-FDA0184F4FEBQ36968104-E1891CE4-71A4-4DEB-98B3-A6DC33755013Q36981609-0B4DD566-E072-44D8-BD98-CADF3EC334EBQ37025497-9F130D5C-7F10-4836-84B5-1C98BAB05C02Q37107171-120113F6-F19E-4180-8DDD-43972560A745Q37170258-49896C4A-2994-482D-95EC-2A5D60A5A776Q37261494-A82E1D1D-343D-47AE-934F-06D1E4081B6BQ37348002-AEB293FA-6911-48A2-B5B9-14DF59E272DEQ37523788-627CF605-EEE6-4921-939A-DF98579537E3Q37582392-F05A09A5-9B08-49C3-9CB6-DE8431FC4BD0Q37586857-2D799398-A988-48A6-AD5C-D1E0C4E94416Q37603804-99C1A305-1F75-4509-B24F-E08EA4DBC023Q37768188-25C4F156-EC38-4A39-8457-A4105E85E467Q38038330-7539F00D-7842-4C7E-AAC9-7632452742C5Q38220276-2EA9495A-0377-4DC7-B552-22CA92F33BA3Q38610456-E64EF523-C474-4B4B-8A9C-D54AEB9C9E91
P2860
Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems.
description
1995 nî lūn-bûn
@nan
1995 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի մարտին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Injury to the lung from cancer ...... and potential scoring systems.
@ast
Injury to the lung from cancer ...... and potential scoring systems.
@en
Injury to the lung from cancer ...... and potential scoring systems.
@nl
type
label
Injury to the lung from cancer ...... and potential scoring systems.
@ast
Injury to the lung from cancer ...... and potential scoring systems.
@en
Injury to the lung from cancer ...... and potential scoring systems.
@nl
prefLabel
Injury to the lung from cancer ...... and potential scoring systems.
@ast
Injury to the lung from cancer ...... and potential scoring systems.
@en
Injury to the lung from cancer ...... and potential scoring systems.
@nl
P2093
P1476
Injury to the lung from cancer ...... and potential scoring systems.
@en
P2093
P304
P356
10.1016/0360-3016(94)00429-O
P407
P577
1995-03-01T00:00:00Z